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Background Home ultraviolet B (UVB) phototherapy is a debated treatment. It is
currently being prescribed for patients with psoriasis, although literature on the
subject is scarce. Despite the apparent contradiction between clinical practice and
literature, no systematic study of either has been conducted.
Objectives To assess and compare the available publications and guidelines about
home UVB phototherapy for psoriasis with the actual opinions and use of this
therapy.
Methods The literature and guidelines were searched using databases, search
engines and e-mail. A postal survey of 343 Dutch dermatologists and 142 derma-
tologists from 32 other countries was carried out; 255 and 102 dermatologists
respectively responded. Outcome measures were the reported advantages, draw-
backs and prescription rates of home UVB phototherapy.
Results Fourteen publications (nonrandomized) and six guidelines concerning
home UVB phototherapy for psoriasis were identified. Most were reticent about
the use of this treatment. Publications describing nonclinical research (7/14)
reported most of the drawbacks mentioned (24/31). Home UVB phototherapy
was prescribed to 5% (median) of all patients with psoriasis in the Netherlands
who required UVB. However, 28% (68/244) of the Dutch dermatologists pre-
scribed home UVB in 20 to 100% of their cases. Dermatologists from other coun-
tries reported that 0–10% of UVB treatments were offered at home. For both
Dutch and other dermatologists, the most important reasons for prescribing home
UVB concerned time and travel distance (80%, i.e. 163 of 205 and 75%, i.e. 33 of
44). Therapy-related drawbacks (such as poor service and equipment) were the
objections mentioned most often (55%, i.e. 103 of 186 and 63%, i.e. 57 of 91).
Concerns about the medicolegal liability of home UVB were rarely expressed by
individual respondents, but frequently mentioned in the various reports.
Conclusions A discrepancy exists between the actual use of home UVB phototherapy
and the general opinions found in publications. The treatment is prescribed for a
considerable number of patients despite the fact that literature and guidelines
advise caution. Personal and nonevidence-based opinions on this therapy are
widespread while randomized clinical studies have thus far not been conducted.
Home ultraviolet B (UVB) phototherapy was introduced in the
late 1970s.1–4 Since then it has been successfully used, mainly
for the treatment of psoriasis.3–10 However, several dermatolo-
gists have raised concerns, in particular about its safety and
effectiveness, as well as patient compliance with this form of
therapy.5,6,10–15 Surprisingly, very little research on home
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UVB phototherapy has been conducted to justify or dismiss
these concerns. As such, the use of home UVB phototherapy
for psoriasis remains debated in dermatology.
In the Netherlands too, varying opinions exist as to the
advisability of prescribing home UVB phototherapy. Recently
the Netherlands Society for Dermatology and Venereology
published an official national guideline on the use of
photo(chemo)therapy in patients with severe psoriasis, in
which prescription of home UVB phototherapy is explicitly
discouraged.11,16 However, many Dutch dermatologists do
prescribe home UVB phototherapy. Informal evidence indi-
cates that two home care institutions are successfully provi-
ding equipment and supervision for about 1400 Dutch
psoriasis patients annually (unpublished registry data from the
home care institutions and one published magazine article).9
Likewise, it has been estimated for the U.S.A. and Germany
that respectively at least 5000 and 3000 home UV photo-
therapy machines (full body length panels) have been sold to
date (unpublished sales figures from four manufacturers in
Europe and four in the U.S.A.).
It appears that home UVB phototherapy for psoriasis may
be prescribed more often than is generally recognized. The
opinions of dermatologists who use this therapy may diverge
from the more cautious messages encountered in the sparse
literature on this subject. Despite the apparent contradiction
between clinical practice and the general tenor of the litera-
ture, neither has been the subject of a systematic study. As
such, it may be useful to compare the actual opinions of der-
matologists about this treatment with those postulated in the
literature. Therefore the aim of this study was to assess and
compare the available publications and guidelines for home
UVB phototherapy for psoriasis with the opinions and actual
use of this therapy among dermatologists.
Materials and methods
Literature and guidelines
The search of literature and guidelines on the subject of home
UVB phototherapy for psoriasis was performed using PubMed/
Medline, Embase, Cochrane, a web browser (Google), and
cross-reference searches. The following search terms were used:
phototherapy, home, home care, psoriasis, ultraviolet therapy,
UV, UVB, treatment, guidelines, protocol, clinical protocols
and treatment protocol. Single search terms and combinations
of terms were used. In addition, the national dermatological
societies of 25 countries were contacted by e-mail in order to
inquire whether national guidelines on the use of (home) photo-
therapy or on psoriasis were available.
Questionnaires
The Netherlands
All Dutch dermatologists (n ¼ 343) received a questionnaire
concerning home UVB phototherapy for psoriasis. In order
to achieve a high response rate, we developed a short one-
page form with open questions. One question addressed the
respondent’s frequency of prescription of home UVB photo-
therapy (as a percentage of his/her total number of pre-
scriptions of UVB phototherapy for psoriasis). Other
questions related to the advantages and drawbacks of this
therapy as perceived by the respondent. Where respondents
indicated that they did prescribe home UVB phototherapy,
we asked them to state their most important reasons for
doing so. All questions concerned only total body home
UVB phototherapy for patients with psoriasis, thus excluding
UVA therapy, small or hand-held devices, and indications
other than psoriasis.
Other countries
To discover the extent of home UVB phototherapy use for
psoriasis in other countries, a comparable questionnaire was
sent to a selection of dermatologists from around the
world. For this purpose, the original Dutch questionnaire
was translated into English. However, we did not ask our
foreign respondents to describe their own practice, but
rather to estimate the prescription frequency for their coun-
try and to give their country’s view of home UVB photo-
therapy. A list of recipients was compiled from several
sources: the European Society for PhotoDermatology, the
Photomedicine Society, several national dermatological soci-
eties, the American Academy of Dermatology and the inter-
net. Whenever possible, we selected dermatologists who
specialize in psoriasis or in phototherapy. In total, question-
naires were posted to 142 dermatologists from 32 coun-
tries. Appendix 1 presents the number of recipients and
respondents per country.
Analysis
The results of the questions concerning the prescription rate
of home UVB phototherapy are presented as percentages
of the total number of UVB phototherapy prescriptions
for psoriasis. The answers to the other open questions
were recorded and coded. We used summary terms such as
‘therapy-related advantages’, ‘dermatologists’ objections’ and
‘convenience’ to reflect the different categories of reported
advantages, drawbacks and reasons for prescribing home
UVB. Results are presented as percentages; i.e. the number
shown is equal to the percentage of the respondents men-
tioning this specific reason, advantage or drawback. Differ-
ences between the Netherlands and the other countries with
regard to the response categories were estimated by calcula-
ting the differences in proportions with a 95% confidence
interval (95% CI). To establish whether differences between
the Netherlands and other countries can be accounted for
by differences in experience, we calculated the differences
between ‘experienced’ dermatologists and ‘inexperienced’
dermatologists for both groups. Experienced dermatologists
were those prescribing home UVB (or reporting the use
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of home UVB in their country), and ‘inexperienced’ derma-




The literature search revealed a total of 25 articles relating to
home phototherapy, of which only 14 specifically concerned
home UVB treatment for psoriasis. The most important fea-
tures of these 14 publications are shown in Table 1. Interest-
ingly, only seven of these articles describe clinical research, of
which only two compare two groups of patients. Neither was
a randomized study.8,15 Twelve publications mention draw-
backs of home UVB phototherapy, and all but one report
advantages. Drawbacks are mentioned more often in com-
ments, reports and position papers, and less often in clinical
studies. Important objections include the lack of medical
supervision, higher risks (including phototoxicity), and
uncontrolled use of the equipment after the treatment period.
Benefits related to time and travel (reduction in absenteeism,
saving of time) and to convenience and reduced medicaliza-
tion are the most frequently mentioned advantages of home
UVB. Potential benefits related to costs are also mentioned
many times.
Of the additional 11 publications on home phototherapy,
five investigated the use of commercial sunbeds.17–21 Another
six publications dealt with home phototherapy for diseases
other than psoriasis.1,2,22–25
Guidelines
Despite a very extensive search, we found only one national
guideline explicitly dealing with home UVB phototherapy.
This guideline is the report of the British Photodermatology
Group 1996 workshop on home phototherapy.12 Several offi-
cial national guidelines on psoriasis or phototherapy were
found, but only four of these contained some information on
home UVB phototherapy.16,26–28
From Germany we obtained a copy of a consensus letter
written on 18 February 1999 on behalf of two German der-
matological societies and the German psoriasis confederation.
This mutual statement concerns home UV phototherapy for
patients with psoriasis and was addressed to the association of
German health insurance companies (not published, copy can
be obtained from first author).
In general, all the guidelines are reticent about home UV
phototherapy, and recommend restricting its use as well as a
careful selection of patients. Only four guidelines specify what
they presume are the hazards of home UVB. Three of them
suggest that the medical supervision is insufficient, that the
treatment gives suboptimal results and has higher attendant
risks, and mention medicolegal liability as a point of concern.
A summary of the most important issues contained in these
guidelines is displayed in Table 2.
Questionnaires
Response
From 9 September 2003 to 31 January 2004, 255 Dutch der-
matologists (74%) completed and returned the questionnaire.
Of the 255 respondents, 19% were working in a university
hospital, 77% in a nonuniversity hospital, and 2% in private
practice. Comparable percentages for the original population
(n ¼ 343) were 23%, 72% and 3%, respectively.
Regarding the worldwide survey, 102 questionnaires (72%)
were completed and returned between 13 November 2003
and 9 March 2004. From each selected country at least one
completed questionnaire was obtained (100% response for the
countries).
Home ultraviolet B prescription rates
Of the 255 responding Dutch dermatologists, 38 (15%)
never prescribed home UVB phototherapy for patients with
psoriasis, and 211 (83%) prescribed this treatment to a vari-
able extent. Six respondents (2%) did not prescribe UVB
treatment at all. A total of 244 Dutch respondents calculated
their prescription rate of home UVB as a percentage of their
total number of UVB prescriptions for psoriasis. Likewise, 98
of the 102 respondents from abroad estimated the home
UVB prescription frequency for their country. A graphical
representation of the distribution of these prescription rates
is presented in Figure 1. The median prescription rate of
home UVB phototherapy in the Netherlands was 5% of all
UVB treatments for psoriasis. However, 28% (68/244) of
the Dutch dermatologists prescribed home UVB for at least
20% of their UVB-treated psoriasis patients, and nearly 12%
of the Dutch dermatologists (30/244) prescribed home UVB
in 50% or more of their cases. Nine of 244 Dutch dermatol-
ogists (4%) prescribed home UVB phototherapy to 95–100%
of their patients requiring UVB treatment. Concerning the
other countries (Fig. 1b), the majority of the respondents
(56%, 55/98) reported that home UVB phototherapy was
not prescribed in their country at all. Another 18% (18/98)
estimated that home UVB in their country is prescribed to
5% or more of the patients receiving UVB treatment. The
maximum estimated prescription rate was 10%, estimated by
three dermatologists.
Opinions
The different categories of reasons for, and advantages and
drawbacks of, prescribing home UVB phototherapy mentioned
by both groups and their distribution are displayed in Table 3.
The flowchart in Figure 2 shows the different numbers of
respondents for all items.
We found that the most important reasons for prescribing
home UVB concerned ‘time, travelling and obligations’: 80%
(163 of 205 Dutch respondents) vs. 75% (33 of 44 respond-
ents from other countries). Although these figures appear
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almost identical, a different distribution across the subcatego-
ries was observed. For 64% (131/205) of the Dutch derma-
tologists ‘work/study/school’ was the most important
subcategory, but for dermatologists from other countries the
main subcategory was ‘long travel distance/long travel time’
(64%, 28/44).
Likewise, analysing the objection of ‘poor/suboptimal ser-
vice and equipment’ (the Netherlands 35% vs. other countries
37%), we found that Dutch dermatologists ascribed this objec-
tion mainly to human error: ‘poor service/supervision/
feedback’ (30% vs. 18%), while foreign dermatologists saw
more hazards in the equipment (‘poor/inadequate dosimetry’,
9% vs. 24%).
When Dutch dermatologists mentioned some issues signifi-
cantly more or less often than their colleagues from other
countries, the difference is shown with a 95% CI. For
instance, non-Dutch dermatologists assumed higher risks of
complications and higher costs of treatment, respectively 22%
and 20% more frequently than did their Dutch colleagues.
Of all the statistically significant differences between both
groups, only three are possibly attributable to differences in
experience: the advantage of ‘convenience’, ‘therapy-related
advantages’ and the fear of ‘higher risks’. The first two were
mentioned significantly more often by experienced Dutch
dermatologists than by their inexperienced Dutch colleagues,
while the fear of higher risks was mentioned less often by
experienced Dutch dermatologists. Within the group of
respondents from other countries, no statistically significant
differences were shown between dermatologists reporting the
use of home UVB in their country and those reporting no use
of this therapy.
Eligibility criteria
Some respondents indicated that, when prescribing home
UVB, they impose some eligibility criteria upon their patients,
such as intelligence, compliance, motivation and experience.
Of the Dutch dermatologists, 18% (44/245) reported using
such eligibility criteria (95% CI ¼ 13Æ2–22Æ8), compared with
14% (14/97) of the respondents from other countries (95%
CI ¼ 7Æ4–21Æ4).
Medicolegal liability
As the medicolegal liability of home UVB phototherapy was
mentioned both as a possible drawback as well as a question
posed to the investigator, this aspect was analysed separately.
Only 22 of 245 Dutch dermatologists (9%, 95% CI ¼ 5Æ4–
12Æ6), and 14 of 97 respondents from other countries (14%,
95% CI ¼ 7Æ4–21Æ4) expressed concerns about this aspect.
Discussion
A discrepancy exists between the actual use of home UVB treat-
ment and the opinions found in the literature and guidelines.























































































































































































































































































































































































































































































































































































































































































































































































 2006 British Association of Dermatologists • British Journal of Dermatology 2006 154, pp701–711







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 2006 British Association of Dermatologists • British Journal of Dermatology 2006 154, pp701–711
706 No consensus on home UVB phototherapy, M.B.G. Koek et al.
while the literature and guidelines suggest that it should be used
with caution. In reality, very little is known about this therapy.
No randomized research has yet been conducted, and only two
observational studies comparing two groups of patients have
been performed.8 Nevertheless, home UVB is currently being
prescribed in appreciable frequencies and personal and nonevi-
dence-based opinions on this therapy are widespread.
In this study of home UVB phototherapy we included and
analysed all available literature on the topic and every relevant
guideline found or brought to our attention. Therefore, to the
best of our knowledge, the review of literature and guidelines
is complete. The questionnaire survey allowed for an explora-
tion of the actual use of home UVB phototherapy for psoriasis
as well as the personal opinions of dermatologists. Neither
had been investigated previously. The response rates to the
questionnaire were high, 74% and 77%, respectively. On the
other hand, the questionnaire was not standardized and valid-
ated. Also, categorizing the answers to the open questions left
room for interpretation. Another point of consideration is that
the questionnaire was sent to all Dutch dermatologists (343),
but to only a relatively small selection of dermatologists from
other countries (142). Consequently, dermatologists from
other countries were asked to give answers concerning their
country as a whole, while the answers given by the Dutch
dermatologists reflect their personal situation and opinion. It
is not unlikely that some of the differences shown between
both groups of dermatologists were caused by this difference
in selection.
All guidelines and the majority of the literature are reserved
about the use of home UVB phototherapy. Interestingly, the
nonclinical publications5,9–14 report far more drawbacks of
home UVB than do the clinical studies.3,4,6–8,15,29 For both
the nonclinical publications and the guidelines we conclude
that the expressed opinions are largely negative and mostly
repeat the statements made in earlier publications. To a large
extent these are personal views based on opinion and belief
rather than on evidence from clinical research. The clinical
studies seem to generate more positive conclusions, mention-
ing more advantages than drawbacks. Still, these authors also
offer mostly personal opinions rather than evidence-based
conclusions.
Regarding the questionnaire, almost all of the objections
raised by our respondents are related to fear (poor dosimetry,
lack of confidence in patients, fear of losing control, fear of
more and ⁄or more serious complications, etc.), while only a
few objections have been verified through experience or med-
ical evidence. This is consistent with the results from our
study of the literature and guidelines. The opinions on home
UVB reported by individual dermatologists, however, only
partially agreed with those cited in the literature and guide-
lines. For instance, financial advantages were frequently men-
tioned in the literature,3–6,8,10,14 but were reported by only a
minority of our respondents. On the other hand, therapy-rela-
ted benefits were quite frequently mentioned by the individual
respondents (mainly Dutch), but not at all in the literature.












50 – < 95%
20 – < 50%
10 – < 20%
0%
5 – < 10%
> 0 – <5%
95 – 100%
Fig 1. Home ultraviolet B (UVB) phototherapy prescription rates for patients with psoriasis. The figure presents home UVB prescription rates in
the Netherlands and in other countries. Dutch dermatologists estimated to what extent they prescribed home UVB phototherapy for their psoriasis
patients requiring UVB. Dermatologists from other countries estimated the prescription rate for their country.
Had remarks on home UVB therapy
n  =  245 vs. 97
Mentioned reasons to prescribe 
n  =  205 vs. 44
Mentioned advantages 
n  =  140 vs. 72
Mentioned drawbacks 
n  =  186 vs. 91
Other remarks, like medico legal liability,
eligibility criteria, experiences etc.
Prescription home UVB 
n  =  211 vs. 45*
Respondents
n  =  255 vs. 102
Survey population
n  =  343 vs. 142
Fig 2. Flowchart: numbers of respondents from the Netherlands vs.
respondents from other countries. *The Netherlands: number of
respondents prescribing home UVB phototherapy. Other countries:
number of respondents reporting the use of home UVB treatment in
their country.
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Also, the presumed higher risks of home UVB were an
important objection in both the literature and the guide-
lines,5,11,12,15,16,26 but only one of 10 Dutch dermatologists
considered home UVB to carry a higher risk of complications.
While the first of these three differences (the question of
costs) may be explained by the somewhat wider perspective
taken in the literature compared with individual opinions, the
other two differences (therapy-related benefits, higher risks)
may be attributed to the relatively broad experience of pre-
sent-day (Dutch) dermatologists compared with the authors of
most of the publications at the time of publication.
Last, but not least, the question of medicolegal liability
regarding home UVB phototherapy was an important con-
cern expressed in almost half of the literature and guide-
lines,5,8,10–12,14,16 but only a minority of the respondents
mentioned it. We conclude that whereas the medicolegal
liability with regard to home UVB phototherapy seems
important in theory, in practice it is not perceived as such.
Despite the differing opinions, the results of the question-
naires showed that a considerable number of dermatologists
prescribes home UVB phototherapy, especially in the Nether-
lands. This is probably due to the easily accessible system in
the Netherlands: home UVB phototherapy equipment can, on
prescription from a dermatologist, be rented from home care
companies. In addition to the high prescription rates that we
found, four previous studies revealed that 25–50% of the pso-
riasis patients apply self treatment with commercial sun-
beds.19,20,29,30 Based on these facts we conclude that home
(UVB) phototherapy is an important therapy for many psori-
asis patients, despite the more guarded opinions of
professionals.
In conclusion, despite the scarcity of literature and guide-
lines on home UVB phototherapy, personal and nonevidence-
based opinions on this therapy are widespread. Moreover, a
considerable proportion of (particularly Dutch) dermatologists
prescribes home UVB phototherapy to many of their patients.
However, according to the official opinion, home UVB photo-
therapy should still be used with caution. Home UVB photo-
therapy remains a contentious and debated treatment,
especially with regard to issues like effectiveness, side-effects,
quality of life and cost-effectiveness. Only randomized
research into the benefits and drawbacks of home UVB photo-
therapy as compared with UVB phototherapy administered in
an outpatient setting will resolve the issue.
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Appendix 1
Number of questionnaire recipients and respondents per coun-
try.
Table A1 Number of dermatologists addressed per country
and number responding: country (n recipients/n respondents)
Argentina (5/1) Germany (10/6) Norway (3/2)
Australia (4/2) Greece (3/1) Philippines (3/1)
Austria (3/3) Hungary (6/1) Portugal (3/2)
Belgium (7/4) Iceland (3/2) South Africa (3/2)
Canada (5/4) Ireland (3/3) Spain (6/5)





Denmark (4/2) Japan (3/2) Thailand (3/2)
Egypt (3/3) Korea (3/2) Turkey (3/2)
Finland (3/2) The Netherlands
(343/255)
U.K. (6/6)
France (12/10) New Zealand
(3/3)
U.S.A. (10/10)
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